Considerations for ANDA and BPCIA Litigation

Matthew Chivvis, life sciences IP litigation partner in Morrison & Foerster’s San Francisco office led session 5 of our course on Legal Topics for Scientists, Entrepreneurs, and Start Ups. Matthew discussed the Hatch-Waxman and Biologics Price Competition and Innovation Act for generics and biosimilars. As part of his discussion, he addressed exclusivities and how litigation is initiated under each act.

We will kick off 2021 with James Mullen, patent partner, teaching the session 6 this Wednesday January 6 on the PCT application process and international patent prosecution.

We are wishing you all a Happy and Healthy New Year.